Own the gold standard ✨ in financial data & analytics
fair value · 20 million securities worldwide · 50 year history · 10 year estimates · leading business news

Subscribe for $2
Overview
Profile

Archit Organosys stock price, quote, forecast and news

524640.BO
INE078I01011

Price

49.99 INR
Today +/-
-0.01 INR
Today %
-1.41 %
P

Archit Organosys stock price

INR
%
Weekly
Details

Price

ⓘ

Overview

The Quote Chart provides detailed and dynamic insights into the Archit Organosys stock's performance, showcasing daily, weekly, or monthly aggregated quotes. Users can switch between different time frames to analyze the stock's progression meticulously and make informed investment decisions.

Intraday Feature

The intraday feature provides real-time data, allowing investors to view the Archit Organosys stock’s price fluctuations within the trading day, facilitating timely and strategic investment decisions.

Total Return and Relative Price Change

View the total return of the Archit Organosys stock to gauge its profitability over time. The relative price change, based on the first quote available in the selected timeframe, offers insights into the stock’s performance, assisting in evaluating its investment potential.

Interpretation and Investment

Utilize the comprehensive data presented in the Quote Chart to analyze Archit Organosys's market trends, price movements, and potential returns. Make informed investment choices by comparing different time frames and evaluating intraday data for optimized portfolio management.

Archit Organosys Stock Price History

DateArchit Organosys Price
9/20/202449.99 INR
9/19/202450.70 INR
9/18/202449.88 INR
9/17/202450.96 INR
9/16/202452.29 INR
9/13/202451.16 INR
9/12/202449.00 INR
9/11/202450.00 INR
9/10/202448.14 INR
9/9/202447.29 INR
9/6/202448.49 INR
9/5/202448.25 INR
9/4/202448.31 INR
9/3/202448.00 INR
9/2/202449.87 INR
8/30/202449.31 INR
8/29/202450.00 INR
8/28/202449.90 INR
8/27/202450.39 INR
8/26/202449.50 INR
8/23/202451.40 INR

Archit Organosys Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into Archit Organosys, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Archit Organosys from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Archit Organosys’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of Archit Organosys. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into Archit Organosys’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing Archit Organosys’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Archit Organosys’s growth potential.

Archit Organosys Revenue, EBIT and net profit per share

DateArchit Organosys RevenueArchit Organosys EBITArchit Organosys Net Income
20241.13 B INR12.01 M INR32.76 M INR
20231.28 B INR146.89 M INR113.49 M INR
20221.37 B INR124.29 M INR82.32 M INR
2021945.11 M INR76.17 M INR50.07 M INR
2020766.9 M INR1.38 M INR-8.01 M INR
2019839.96 M INR-56.77 M INR-47.16 M INR
2018817.1 M INR12.03 M INR5.17 M INR
2017484.88 M INR32.83 M INR17.13 M INR
2016513.54 M INR26.04 M INR14.66 M INR
2015555.37 M INR17.08 M INR7.96 M INR
2014489.9 M INR13 M INR6 M INR
2013384 M INR9.7 M INR5.1 M INR
2012464.4 M INR11 M INR6.7 M INR
2011423.6 M INR8.9 M INR3.1 M INR

Archit Organosys Income Statement, Balance Sheet, Cash Flow Statement

  • Simple

  • Expanded

  • Income Statement

  • Balance Sheet

  • Cashflow

 
REVENUE (B INR)REVENUE GROWTH (%)GROSS MARGIN (%)GROSS INCOME (M INR)EBIT (M INR)EBIT MARGIN (%)NET INCOME (M INR)NET INCOME GROWTH (%)DIV. (INR)DIV. GROWTH (%)SHARES (M)DOCUMENTS
20112012201320142015201620172018201920202021202220232024
0.420.460.380.490.560.510.480.820.840.770.951.371.281.13
-9.69-17.2427.3413.50-7.57-5.6568.802.69-8.7023.3744.55-6.52-11.43
13.7113.3629.1723.1124.6830.4128.3123.1312.5125.4631.5326.5035.3225.55
5862112113137156137189105195298362451289
81191317263212-5617612414612
1.892.372.342.663.065.076.611.47-6.670.138.049.0811.431.06
3656714175-47-8508211332
-100.00-16.6720.0016.67100.0021.43-70.59-1,040.00-82.98-725.0064.0037.80-71.68
--------------
--------------
5.85.85.85.85.786.019.7512.0515.0215.0215.0220.5220.5220.52
--------------
Details

Keystats

ⓘ

Revenue and Growth

The Archit Organosys Revenue and Revenue Growth are pivotal to understanding the company's financial health and operational efficiency. A consistent increase in revenue indicates a company’s ability to effectively market and sell its products or services, while the revenue growth percentage offers insights into the pace at which the company is expanding over the years.

Gross Margin

The Gross Margin is a crucial metric that showcases the percentage of revenue exceeding the cost of goods sold (COGS). A higher gross margin is indicative of a company’s efficiency in controlling its production costs, thereby promising potential profitability and financial stability.

EBIT and EBIT Margin

EBIT (Earnings Before Interest and Taxes) and EBIT Margin offer deep insights into a company’s profitability, excluding the impacts of interest and taxes. Investors often assess these metrics to gauge the operational efficiency and inherent profitability of a business, separate from its financial structure and tax environment.

Income and Growth

Net Income and its subsequent growth are quintessential for investors looking to understand a company’s profitability. Consistent income growth underscores a company’s ability to enhance its profitability over time, reflecting operational efficiency, strategic competitiveness, and financial health.

Shares Outstanding

Shares outstanding refer to the total number of shares a company has issued. It's instrumental in calculating key metrics like Earnings Per Share (EPS) which is pivotal for investors to evaluate a company’s profitability on a per-share basis, offering a more granular view of financial health and valuation.

Interpreting Year to Year Comparison

Comparing yearly data allows investors to identify trends, assess the company’s growth, and anticipate potential future performance. Analyzing how metrics like revenue, income, and margins change year over year can provide valuable insights into the company’s operational efficiency, competitiveness, and overall financial health.

Expectations and Predictions

Investors often juxtapose the current and past financial data with the market’s expectations. This comparison aids in assessing whether the Archit Organosys is performing as anticipated, underperforming or outperforming the market predictions, providing pivotal data for investment decisions.

 
ASSETSCASH BALANCE (M INR)RECEIVABLES (M INR)OTHER REC. (M INR)INVENTORIES (M INR)OTHER CURRENT LIAB. (M INR)CURRENT ASSETS (M INR)TANGIBLE ASSETS (M INR)LONG-T. INVEST. (M INR)LONG-T. REC. (M INR)INTANGIBLE ASSETS (k INR)GOODWILL (M INR)OTHER NON-CURRENT ASSETS (M INR)NON-CURRENT ASSETS (M INR)TOTAL ASSETS (B INR)LIABILITIESCOMMON STOCK (M INR)ADDITIONAL PAID-IN CAPITAL (M INR)RETAINED EARNINGS (M INR)OTHER EQUITY (M INR)UNREAL. GAINS/LOSSES (M INR)EQUITY (M INR)LIABILITIES (M INR)PROVISIONS (k INR)OTHER SHORT-TERM LIAB. (M INR)SHORT-TERM DEBTS (M INR)LONG-TERM DEBT PORTION (M INR)SHORT-TERM REC. (M INR)LONG-T. LIAB. (M INR)DEFERRED TAXES (M INR)OTHER LIAB. (M INR)LONG-T. LIABILITIES (M INR)DEBT (M INR)TOTAL CAPITAL (B INR)
20112012201320142015201620172018201920202021202220232024
                           
8.524.43.65.39.29.117.2916.6557.4252.9647.8163.0254.1442.2
98.5117.888.8136.6116.2110.57113.37313.62143.51197.23250.05273.53373.56223.94
12.25.48.76.117.70.320.41.0242.433.610.9823.658.03101.64
16.915.91310.132.627.8124.9271.158.4532.8135.3959.3733.8146.28
000.10.20.119.6453.3540.486.0416.077.469.79.90.8
136.1163.5114.2158.3175.8167.45199.34442.87307.84302.67341.68429.28479.44414.86
5854.149.451.966.3143.89481.84549.67518.13514.76506.49578668.77603.59
000000.650.997.827.847.5711.2724.1940.1558.72
0.40.50.51.10.7000000002.03
00000015.967454902342000
00000000000000
000007.9316.6611.636.866.4215.444.0713.383.16
58.454.649.95367152.46499.51569.86533.31528.99533.2606.26722.3667.5
0.190.220.160.210.240.320.71.010.840.830.871.041.21.08
                           
30.330.330.330.330.350.35100.42150.42150.21150.21150.21205.21205.21205.21
00000000000000
-0.85.9111724.978.52165.57245.54199.02190.87255.18313.72412.55436.26
00000000000000
00000000000000
29.536.241.347.355.2128.87265.99395.96349.22341.08405.38518.93617.76641.46
69.16243.182.285.761.7874.77216.29106.17129.15146.11135.58231.89134.56
000000485.740000000
10.17.92.72.3912.530.59106.4668.2112.6813.5634.9319.4126.39
73.284.552.958.37477.5246.1382.69136.63143.0395.85115.43114.56135.64
000003.6116.7721.6170.9187.2590.153.1846.07
152.4154.498.7142.8168.7155.41168.75407.44312.62355.77342.77376.05419.04342.65
5.920.7181513.630.37251.76192.25177.33132.43124.1134.16146.3482.74
65.755.24.64.3510.5615.250003.7217.5713.23
0.61.110.90.60.911.791.821.972.382.632.681.032.28
12.527.52421.118.835.64264.11209.33179.31134.82126.73140.56164.9598.25
164.9181.9122.7163.9187.5191.05432.86616.76491.92490.58469.5516.61583.99440.9
0.190.220.160.210.240.320.71.010.840.830.871.041.21.08
Details

Balance Sheet

ⓘ

Understanding the Balance Sheet

The balance sheet of Archit Organosys provides a detailed financial snapshot, revealing the company's assets, liabilities, and equity at a specific point in time. Analyzing these components is crucial for investors looking to understand Archit Organosys's financial health and stability.

Assets

Archit Organosys's assets represent everything the company owns or controls that has monetary value. These are categorized into current and non-current assets, offering insights into the company's liquidity and long-term investments.

Liabilities

Liabilities are obligations that Archit Organosys must settle in the future. Analyzing the ratio of liabilities to assets provides insights into the company's financial leverage and risk exposure.

Equity

Equity refers to the residual interest in the assets of Archit Organosys after deducting liabilities. It represents the owners’ claim on the company’s assets and earnings.

Year-to-Year Analysis

Comparing balance sheet figures year-to-year allows investors to identify trends, growth patterns, and potential financial risks, facilitating informed investment decisions.

Interpreting the Data

Detailed analysis of assets, liabilities, and equity can provide investors with comprehensive insights into Archit Organosys's financial standing, aiding in investment evaluations and risk assessments.

 
NET INCOME (M INR)DEPRECIATION (M INR)DEFERRED TAXES (M INR)CHANGES IN WORKING CAPITAL (M INR)NON-CASH ITEM (M INR)PAID INTEREST (M INR)PAID TAXES (M INR)NET CASH FLOW FROM OPERATING ACTIVITIES (M INR)CAPITAL EXPENDITURES (M INR)CASH FLOW FROM INVESTING ACTIVITIES (M INR)CASH FLOW FROM OTHER INVESTING ACTIVITIES (M INR)INTEREST INCOME AND EXPENSES (M INR)NET DEBT CHANGE (M INR)NET CHANGE IN EQUITY (M INR)CASH FLOW FROM FINANCING ACTIVITIES (M INR)CASH FLOW FROM OTHER FINANCING ACTIVITIES (INR)TOTAL DIVIDENDS PAID (M INR)NET CHANGE IN CASH FLOW (M INR)FREE CASH FLOW (M INR)SHARE-BASED COMPENSATION (M INR)
2011201220132014201520162017201820192020202120222023
58681423293-62-746114153
3332435252734364648
0000000000000
-11-222-7-12-25-16-1003124-4-710
9911610753230263116-6
101697896363530312220
002239531001431
7-1241116822-372777111106194
-9-5-2-5-21-81-348-100-38-52-31-108-165
-970-4-20-81-346-9410-8-28-115-135
01211002649432-629
0000000000000
1326-34215202064539-58-5515-11
00000601211240013410
39-43-57713201333-88-7324-61
-10.00-16.00-9.00-7.00-8.00-9.00-6.00-36.00-35.00-30.00-31.00-22.00-34.00
00000000000-10-15
115-19130-2141-19815-2
-1.87-6.1722.185.56-4.43-72.95-326.05-138.28-11.4525.2679.52-2.1829.48
0000000000000

Archit Organosys stock margins

The Archit Organosys margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Archit Organosys. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Archit Organosys.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the Archit Organosys's sales revenue. A higher gross margin percentage indicates that the Archit Organosys retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the Archit Organosys's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the Archit Organosys's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Archit Organosys's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Archit Organosys. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Archit Organosys's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

Archit Organosys Margin History

Archit Organosys Gross marginArchit Organosys Profit marginArchit Organosys EBIT marginArchit Organosys Profit margin
202425.59 %1.06 %2.89 %
202335.32 %11.5 %8.88 %
202226.5 %9.09 %6.02 %
202131.54 %8.06 %5.3 %
202025.43 %0.18 %-1.04 %
201912.57 %-6.76 %-5.61 %
201823.24 %1.47 %0.63 %
201728.4 %6.77 %3.53 %
201630.56 %5.07 %2.85 %
201524.83 %3.08 %1.43 %
201423.19 %2.65 %1.22 %
201329.19 %2.53 %1.33 %
201213.42 %2.37 %1.44 %
201113.74 %2.1 %0.73 %

Archit Organosys Stock Sales Revenue, EBIT, Earnings per Share

The Archit Organosys earnings per share therefore indicates how much revenue Archit Organosys has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Sales per Share
EBIT per share
Earnings per Share
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Archit Organosys earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Archit Organosys's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Archit Organosys’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Archit Organosys's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Archit Organosys Revenue, EBIT and net profit per share

DateArchit Organosys Sales per ShareArchit Organosys EBIT per shareArchit Organosys Earnings per Share
202455.16 INR0.59 INR1.6 INR
202362.27 INR7.16 INR5.53 INR
202266.6 INR6.06 INR4.01 INR
202162.92 INR5.07 INR3.33 INR
202051.06 INR0.09 INR-0.53 INR
201955.92 INR-3.78 INR-3.14 INR
201867.81 INR1 INR0.43 INR
201749.71 INR3.37 INR1.76 INR
201685.46 INR4.33 INR2.44 INR
201596.07 INR2.96 INR1.38 INR
201484.47 INR2.24 INR1.03 INR
201366.21 INR1.67 INR0.88 INR
201280.07 INR1.9 INR1.16 INR
201173.03 INR1.53 INR0.53 INR

Archit Organosys business model

Archit Organosys is one of the most popular companies on Eulerpool.com.

Archit Organosys Eulerpool Fair Value

Details

Fair Value

ⓘ

Understanding Fair Value

The fair value of a stock provides insights into whether the stock is currently undervalued or overvalued. It is calculated based on profit, revenue, or dividends and offers a comprehensive perspective of the stock’s intrinsic value.

Income-Based Fair Value

This is calculated by multiplying the earnings per share by the average P/E ratio of the selected past years for smoothing. If the fair value is higher than the current market price, it suggests that the stock is undervalued.

Example 2022

Fair Value Profit 2022 = Earnings per Share 2022 / Average P/E Ratio 2019 - 2021 (3 Years Smoothing)

Revenue-Based Fair Value

It is derived by multiplying the revenue per share by the average price-to-sales ratio of the selected past years for smoothing. An undervalued stock is identified if the fair value exceeds the ongoing market price.

Example 2022

Fair Value Revenue 2022 = Revenue per Share 2022 / Average PSR 2019 - 2021 (3 Years Smoothing)

Dividend-Based Fair Value

This value is determined by dividing the dividend per share by the average dividend yield of the selected past years for smoothing. A higher fair value than the market price indicates an undervalued stock.

Example 2022

Fair Value Dividend 2022 = Dividend per Share 2022 * Average Dividend Yield 2019 - 2021 (3 Years Smoothing)

Expectations and Forecasts

Future expectations provide potential trajectories for stock prices and aid investors in decision-making. The expected values are forecasted figures of fair value, taking into account the growth or decline trends of profit, revenue, or dividend.

Comparative Analysis

Comparing the fair value based on profit, revenue, and dividend provides a holistic overview of the stock’s financial health. Observing the annual and per-annual variations contributes to understanding the consistency and reliability of stock performance.

Archit Organosys historical P/E ratio, EBIT, and P/S ratio.

Archit Organosys shares outstanding

The number of shares was Archit Organosys in 2023 — This indicates how many shares 20.521 M is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Number of stocks
Details

Revenue, EBIT and Earnings per share

ⓘ

Revenue Per Share

Revenue per share represents the total revenue Archit Organosys earns, divided by the number of outstanding shares. It is a crucial metric as it reflects the company's ability to generate sales and signifies growth and expansion potential. Comparing yearly revenue per share allows investors to analyze the consistency in a company’s earnings and predict future trends.

EBIT Per Share

EBIT per share indicates Archit Organosys's earning before interest and taxes, offering insights into operational profitability excluding the effects of capital structure and tax rates. It can be juxtaposed against revenue per share to gauge the efficiency in converting sales into profits. A consistent increase in EBIT per share over the years underscores operational efficiency and profitability.

Income Per Share

Income per share, or earnings per share (EPS), reveals the portion of Archit Organosys’s profit allocated to each share of common stock. It’s instrumental in evaluating the profitability and financial health. By comparing it with revenue and EBIT per share, investors discern how effectively a firm translates sales and operational profits into net income.

Expected Values

Expected values are projections of revenue, EBIT, and income per share for forthcoming years. These anticipations, rooted in historical data and market analysis, aid investors in strategizing their investments, evaluating Archit Organosys's prospective performance, and estimating future stock prices. However, it’s pivotal to consider market volatilities and uncertainties that can influence these projections.

Archit Organosys dividend history and estimates

In 2023, Archit Organosys paid a dividend amounting to 0.5 INR. Dividend means that Archit Organosys distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for Archit Organosys provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify Archit Organosys’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating Archit Organosys's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

Archit Organosys Dividend History

DateArchit Organosys Dividend
20230.5 INR
20220.75 INR
20210.5 INR

Archit Organosys dividend payout ratio

In 2023, Archit Organosys had a payout ratio of 16.85%. The payout ratio indicates the percentage of the company's profits that Archit Organosys distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for Archit Organosys represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for Archit Organosys could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate Archit Organosys's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

Archit Organosys Payout Ratio History

DateArchit Organosys Payout ratio
202416.85 %
202316.85 %
202218.7 %
202115 %
202016.85 %
201916.85 %
201816.85 %
201716.85 %
201616.85 %
201516.85 %
201416.85 %
201316.85 %
201216.85 %
201116.85 %
Unfortunately, there are currently no price targets and forecasts available for Archit Organosys.

Archit Organosys list of shareholders

%
Name
Stocks
Change
Date
7.89666 % Amin (Archit)1,620,395012/31/2023
7.87619 % Amin (Suchit K)1,616,195012/31/2023
22.19380 % Amin (Archana K)4,554,167183,6523/27/2024
20.82570 % Amin (Kandarp K)4,273,43482,1103/28/2024
2.43665 % Amin (Manini)500,000012/31/2023
2.43665 % Amin (Shimoli)500,000012/31/2023
1

Archit Organosys Executives and Management Board

Smt. Archana Amin53
Archit Organosys Whole-Time Director
Compensation 900,000 INR
Shri. Kandarp Amin
Archit Organosys Whole-Time Chairman of the Board
Compensation 420,000 INR
Mr. Ajay Patel
Archit Organosys Chief Financial Officer (since 2022)
Mr. Vijay Boliya
Archit Organosys Company Secretary, Compliance Officer
Mr. Archit Amin
Archit Organosys Whole Time Director (since 2017)
1
2

Most common questions regarding Archit Organosys

What is the P/E ratio of Archit Organosys 2024?

The Archit Organosys P/E ratio is 31.32.

What is the P/S ratio of Archit Organosys 2024?

The Archit Organosys P/S ratio is 0.91.

What is the AlleAktien quality score of Archit Organosys?

The AlleAktien quality score for Archit Organosys is 2/10.

What is the revenue of Archit Organosys 2024?

The Archit Organosys revenue is 1.13 B INR.

How high is the profit of Archit Organosys 2024?

The Archit Organosys profit is 32.76 M INR.

What is the business model of Archit Organosys

No history available for Archit Organosys.

What is the Archit Organosys dividend?

Archit Organosys pays a dividend of 0.75 INR distributed over payouts per year.

How often does Archit Organosys pay dividends?

The dividend cannot currently be calculated for Archit Organosys or the company does not pay out a dividend.

What is the Archit Organosys ISIN?

The ISIN of Archit Organosys is INE078I01011.

What is the Archit Organosys ticker?

The ticker of Archit Organosys is 524640.BO.

How much dividend does Archit Organosys pay?

Over the past 12 months, Archit Organosys paid a dividend of 0.5 INR . This corresponds to a dividend yield of about 1 %. For the coming 12 months, Archit Organosys is expected to pay a dividend of 0.5 INR.

What is the dividend yield of Archit Organosys?

The current dividend yield of Archit Organosys is 1 %.

When does Archit Organosys pay dividends?

Archit Organosys pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Archit Organosys?

Archit Organosys paid dividends every year for the past 0 years.

What is the dividend of Archit Organosys?

For the upcoming 12 months, dividends amounting to 0.5 INR are expected. This corresponds to a dividend yield of 1 %.

In which sector is Archit Organosys located?

Archit Organosys is assigned to the 'Commodities' sector.

Wann musste ich die Aktien von Archit Organosys kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Archit Organosys from 9/30/2023 amounting to 0.5 INR, you needed to have the stock in your portfolio before the ex-date on 8/8/2023.

When did Archit Organosys pay the last dividend?

The last dividend was paid out on 9/30/2023.

What was the dividend of Archit Organosys in the year 2023?

In the year 2023, Archit Organosys distributed 0.75 INR as dividends.

In which currency does Archit Organosys pay out the dividend?

The dividends of Archit Organosys are distributed in INR.

All fundamentals about Archit Organosys

Our stock analysis for Archit Organosys Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Archit Organosys Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.